Skip to main content

Table 2 Effects of dietary soy peptides on growth parameters and activities of hepatic triglyceride metabolism-related enzymes in Otsuka Long-Evans Tokushima fatty rats

From: Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivo

  Control Soy crude peptide-LD3 Hydrophilic peptide
Initial body weight (g) 465 ± 11 467 ± 7 463 ± 9
Final body weight (g) 558 ± 10 554 ± 7 550 ± 8
Food intake (g) 743 ± 3 740 ± 8 738 ± 10
Liver weight (g/100 g b.w.) 3.45 ± 0.05a 3.14 ± 0.05b 3.16 ± 0.06b
Hepatic enzyme activity (nmol/min/mg protein)   
   FAS 17.0 ± 0.7a 13.6 ± 0.8b 13.3 ± 1.3b
   G6PDH 127 ± 7a 82.7 ± 4.2b 77.0 ± 5.2b
   Malic enzyme 115 ± 5a 79.0 ± 3.7b 86.5 ± 2.1b
   PAP 17.3 ± 1.1a 14.5 ± 0.5b 14.8 ± 0.5b
   CPT 5.16 ± 0.31 5.66 ± 0.25 5.42 ± 0.10
  1. FAS, fatty acid synthase; G6PDH, glucose 6-phosphate dehydrogenase; PAP, phosphatidate phosphohydrolase; CPT, carnitine palmitoyltransferase.
  2. Values are expressed as mean ± standard error of 6 rats.
  3. Different superscript letters indicate a significant difference at P < 0.05.